GIST pathogenesis is most frequently attributed to gain-of-function mutations in the receptor tyrosine kinase KIT; however, activating mutations in platelet derived growth factor receptor-α (PDGFRA) have been observed in GISTs with wild-type KIT [1]. Here, PDGFRA is linked to gastrointestinal stromal tumor.